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Abstract
Objectives: To explore understanding, perceptions and feelings about 
meningococcal disease in members of higher risk groups. To explore what 
people say are the most important health messages and communication 
preferences about invasive meningococcal disease (IMD).
Methods: Three focus groups and two semistructured interviews were 
conducted with people at higher risk of IMD in Hunter New England Local 
Health District in New South Wales.
Results: Participants generally had a low understanding of IMD, but 
described intense feelings about the disease and empathy for those who 
had experienced the disease. Fear of stigma and the impact of stigma were 
identified. Participants identified reasons for delaying presentation for care as 
perceptions of invincibility (particularly among young people), the cost of care 
(for all groups), and racism (particularly for Aboriginal people). These issues 
were both potential and experienced barriers for participants accessing 
help when acutely unwell. Factors for effective communication to improve 
understanding of IMD included the communication being acceptable, 
accessible and appropriate.
Conclusions: IMD is a serious but uncommon disease that has a range of 
impacts on people, families and communities. Higher risk groups may benefit 
from receiving more appropriate and accessible information about early signs 
and symptoms of IMD. Communication and understanding about the disease 
could be improved by working with new technologies and partnering with 
key people in high-risk groups. Use of text messages and social networking 
for urgent communication could be considered and trialled in public health 
practice. It is also important to recognise the potential direct or indirect 
experience of racism and stigma for patients with IMD and their families. 
Management of IMD could be strengthened by connecting people and 
families with support groups or services to reduce the impact of the disease.
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Key points
• Community understanding of invasive 
meningococcal disease (IMD) is generally 
low
• Perceptions of invincibility, as well as 
racism and cost of care, are potential 
barriers to people with IMD seeking help 
when acutely unwell
• Public health practice may be 
improved by adopting new methods 
of communication to prompt early 
recognition of the signs and symptoms 
of IMD in ways that are acceptable, 
accessible and appropriate for higher 
risk groups
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Introduction
Invasive meningococcal disease (IMD) is a serious 
but uncommon bacterial infection that usually presents 
as meningitis or septicaemia. Serious complications, 
including amputation, hearing loss and neurological 
problems, can occur. IMD has a case fatality rate of 
7% for meningitis and as high as 19% for septicaemia 
alone.1 Parents of children who have lived through IMD 
experience major emotional stress and, although health 
professionals have some insight into the experience, 
they are largely naive to the enormity of the situation for 
affected families.2
The most recent annual report of IMD notifications 
in Australia, in 2014, reported 0.7 cases per 100 000 
population per year.3 A number of population groups have 
a higher risk of IMD. Aboriginal people are known to have 
a two- to three-fold increased risk of IMD in New South 
Wales (NSW).4,5 Children younger than 4 years of age 
have the highest incidence of IMD, with a secondary peak 
in incidence in adolescents.6 IMD is a notifiable condition 
in Australia, with each case requiring timely public health 
action to reduce ongoing risk to the community.7 Early 
diagnosis, treatment and public health management of 
IMD improve patient outcomes and highlight the need for 
the public to be aware of the disease.7,8
Identifying what members of the public understand 
about IMD and their perceptions of the disease may 
help to inform better public health practice and reduce 
risk. This is the first study of its type to explore current 
understanding, perceptions and feelings of people 
in higher risk groups about IMD in a regional area of 
Australia.
This study aimed to:
• Explore understanding of IMD in higher risk population 
groups, including Aboriginal people, young people 
and parents of young children
• Describe the perceptions and feelings about IMD of 
people in high-risk groups
• Investigate the most important messages about IMD 
for higher risk groups
• Understand ways that people would like to hear 
about IMD.
Method
Focus groups from population groups at higher risk of 
IMD and semistructured interviews with key community 
informants were conducted in a regional area of 
northwestern NSW. Purposive sampling was used to 
direct the formation of the focus groups from community 
networks known to the researchers. This included parents 
of young children (aged less than 10 years), young 
people (18–25 years), community members of lower 
socio-economic areas, and Aboriginal people.
Participants were asked what they knew or had heard 
about IMD and where they got this information. They were 
also asked how they would feel, or had felt, if someone 
close to them had IMD. The focus groups and interviews 
explored what messages were important and how these 
could most effectively be disseminated within their 
communities.
The focus groups and semistructured interviews 
were conducted by the lead researchers (JK and PM), 
recorded and transcribed. Group observations and 
notes were made by two researchers (KT and MO). The 
participants determined the most convenient date and 
time for the project team to conduct the research at a 
venue comfortable for participants.
The transcribed interviews and the notes were 
reviewed and thematically analysed using a modified 
grounded theory approach to developing an explanatory 
theory of basic social processes within the environments 
in which they occur.9 Grounded theory can give voices 
to those who are otherwise rarely heard10, such as 
participants in this research, and is well suited to the aims 
of this study, where the questions guide the research 
without being either static or confining.10 Emerging 
themes and linkages from early interviews were explored 
in subsequent interviews.10 Researchers separately 
coded the data, and the coding system was refined 
iteratively as the notes were reanalysed. Coding was 
deconstructed – breaking the data down into categories 
that described the content – then reconstructed, framing 
the themes or codes within existing theory, evidence 
and practice. Once the coding system was finalised, all 
notes were recoded. Relationships between codes and 
categories were then assessed across the notes. Quotes 
illustrating the themes were then drawn from the notes. 
All authors participated in discussions resulting in the 
themes, and tested these with outlying cases across the 
sample groups’ informants.
Study rigour was improved by having two researchers 
independently conduct the data analysis and then 
discuss emergent themes with the remaining authors. 
This improved ‘reflexivity’, where researchers reflect and 
examine their influence on the assumptions, analysis and 
formation of themes.11,12
The Hunter New England Human Research Ethics 
Committee (10/11/17/5.02) and the Aboriginal Health and 
Medical Research Council Ethics Committee approved 
the study.
Results
Three focus group discussions were conducted with 
8–10 people in each, and semistructured interviews were 
conducted with three key informants. Participants’ ages 
ranged from 18 to 50, and females and males were evenly 
represented in the young people’s group and the lower 
socio-economic community group. The parents of young 
children and the three semistructured interviews involved 
female participants only. At least three of the participants 
were Aboriginal people.
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Even though IMD is an uncommon disease, and 
participants were not chosen for exposure to disease or 
experience of someone affected by IMD, at each focus 
group there was at least one person who had extended 
family or community experience with IMD.
Four main themes emerged from the data: “it’s not 
just normal sickness”; stigma; “just wait and see”; and 
acceptable, accessible and appropriate communication.
“It’s not just normal sickness, it can be life 
threatening and scary with such disastrous 
consequences”
Participants reported that they “really didn’t know that 
much about meningococcal disease” but knew that “it’s 
not just normal sickness”. Participants described the 
importance of needing to know something about this 
disease. One young person said, “you know, stupidly 
I still do not know, really, the signs of meningococcal”. 
Individual knowledge of signs and symptoms was 
acknowledged by the participants as being poor, but, 
collectively at each focus group, the understanding of 
the illness was more complete. Rash was identified as 
a common symptom of IMD in each focus group and 
interview. Participants also described the speed at which 
a person with IMD could deteriorate: “it hits so suddenly” 
and “all of a sudden … they can be unconscious the next 
minute”.
Each group and interview described IMD as serious 
(“such a tragic thing”) and knew that “it can kill”. 
Emotional aspects became important to participants – a 
young person said they “feel pretty helpless, like what on 
earth can you do about it?”.
Participants frequently described sadness in response 
to IMD: “just feel really sad … then you feel sad for 
that family” and they feel “bad and sorry, you know”. 
Along with describing the disease as life threatening, 
genuine concern for both those experiencing IMD and 
their families was described; as one participant said, “it 
would be a very hard time for them as well”. One parent 
participant summarised the conflict of interest that may 
take place when a child has been in contact with a 
person with IMD: “you’ve got to be a parent for your child 
but maybe also still that friend for that person [who has 
the illness]”. The participant spoke with some intensity 
on this point, and this intensity was mirrored in other 
participants with nods of their head or affirmations.
Stigma: “don’t go near them because you’re 
going to catch the disease”
Throughout each focus group and each semistructured 
interview, stigma associated with IMD emerged as a 
strong theme. It was described on two levels: fear of 
stigma and reported stigma.
One young person likened the fear of stigma from IMD 
to stigma from a sexually transmitted disease: “you’re 
a bit ashamed about it … don’t want to tell anyone”. A 
participant described their memories of a child who had 
recovered from meningococcal disease returning to 
school and what ensued: “teased because they’ve had it 
… don’t go near them because you’re going to catch the 
disease”. This stigmatisation went on for many months or 
even years. Participants in two groups then shared how 
they believed those experiencing IMD stigma may feel 
“very isolated”, and another participant shared how family 
members experiencing the impact of the disease coped 
within their community: “no[-one] talking, they just sat and 
listened” because other parents were “afraid to send their 
children to school”.
“Just wait and see”
Participants in the youth focus group spent some time 
relating the feeling of being carefree and invincible. The 
“whole notion of being invincible” and “not really thinking 
about fatal diseases” was described. The young people 
expressed their freedom at this stage of their life where 
they are able to “go out and do whatever they want”, and 
where they “might get a bit lazy in relation to caring for 
yourself” and seeing a doctor when sick.
Other groups and participants described reluctance 
to attend a general practitioner as “either too reluctant or 
too lazy, or that they couldn’t afford to go to the doctor” so 
would just “wait and see”.
Another barrier for participants in presenting to 
a health centre, leading to reticence to seek help, 
was racism. An Aboriginal participant described her 
community members not presenting to health centres 
because of a lack of cultural safety. This resulted in 
parents waiting; she said, “if a child is sick at whatever 
time of … night, they’ll linger it out with Panadol if they 
can” and “a lot of Aboriginal people don’t go to health 
centres unless they have to”.
Acceptable, accessible and appropriate 
communication
Participants described the importance of being informed 
about IMD to “give yourself a better shot at an early 
diagnosis and early treatment”. Participants described 
this as being able to recognise signs and symptoms, so 
they can help people around them and recommend that 
“they go get … checked out”.
An important element of making information more 
acceptable for participants was a ‘go-to’ person 
delivering the message. Participants reported that a 
community nurse, a family member, a friend with health 
experience, or someone who had experienced IMD would 
be good examples of go-to people. These people were 
trustworthy, as were “a government website or medical 
website”. Participants described two key elements for 
information to be appropriate: that the language be 
simple and emotive (“try to keep it as simple as possible” 
but “get emotionally involved … then you’re inquisitive”). 
Participants also identified low or no literacy as a barrier 
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to receiving information, and thought that graphics would 
enable people to visualise the signs and symptoms of 
IMD, and the steps to take.
Participants identified various methods for delivering 
health messages, depending on the urgency and type 
of message. They agreed that an acceptable method to 
deliver urgent public health IMD contact messages would 
be through text messages and social media. Participants 
all said that their phones were with them at all times, and 
that phone plans could include social media platforms, 
making them an acceptable and accessible mode of 
communicating important health messages.
For promoting an understanding of IMD for parents, 
including the signs and symptoms of IMD, a health letter 
and a pamphlet with their child’s immunisation ‘blue book’ 
(personal health record) were identified by participants 
as being acceptable. Other modes of communication 
varied according to the particular group. For example, the 
young people thought that posting health messages on 
screensavers at tertiary institutions, and displaying them 
in pubs and clubs would be worthwhile. The parents’ 
group and community group identified schools as an 
acceptable method for giving health messages to parents 
and students.
There was some concern about the appropriateness of 
newspapers and television or radio news to get messages 
to the high-risk groups. Asked why newspapers and news 
bulletins were not viewed as effective communication by 
parents of young children, the following responses were 
elicited: “We’re busy at 6 o’clock … I’m at home feeding 
children [and not watching the news]” and “we don’t get 
the paper, or, if we do, I just flick through pages and read 
[the] headline[s]”. A community member also said that 
“no-one watches commercial TV today”.
Discussion
IMD is a serious but uncommon disease that has a 
range of effects on people, families and communities. 
For participants who had a lived experience of IMD, the 
experience continued to be very real, and the depth 
of emotion about IMD was evident even when it was 
some time ago. Faber et al. note that human memories 
that remain the most vivid are usually associated with 
strong emotional events containing extreme fear, love 
or rage.13 IMD can cause this level of fear among family 
members and the wider community, as described by the 
participants.
In addition to fear, the focus groups and interviews 
revealed the need for understanding of perceptions 
and other feelings about IMD in communities and for 
healthcare professionals. This need aligns with previous 
IMD research that has described survivors’ challenges 
with quality of life, and their physical, cognitive, 
educational and psychological outcomes.14 Also 
resonating with the current research were issues pertinent 
to the journey during and after a child’s IMD diagnosis, 
previously described by parents.15 These issues included 
a need for better education and improved knowledge in 
healthcare professionals, improved access to information 
about sequelae, and easier access to follow-up support 
and advice.15
An important finding for public health practice was 
that individual knowledge about IMD was generally low 
and indicated some misunderstanding about transmission 
of the disease. A study by Wang et al. also identified large 
knowledge gaps about IMD among community members 
in Australia.16 Despite low individual knowledge, including 
about signs and symptoms of IMD, all participants knew 
about the seriousness of the infection, and that IMD is 
a frightening, life-threatening illness. This knowledge 
and fear have been described previously in research 
showing that IMD is one of the diseases that parents 
most worry about their child contracting.17 A rash is a late 
IMD symptom and was identified in each focus group, 
yet earlier signs and symptoms (such as very high fever, 
or cold hands and feet) were not stated. Waiting for 
late symptoms can increase the risk of poor outcomes8; 
therefore, further public health education may be 
required to increase understanding of the early signs and 
symptoms of IMD.
Although participants described meningococcal 
disease as life threatening and scary, some groups in 
the community may delay seeking healthcare for reasons 
including a feeling of ‘invincibility’, cost of care and 
racism.18 Delaying nonurgent medical review because of 
cost has been reported elsewhere and, in Australia, the 
proportion of people delaying or not seeing a general 
practitioner for primary care has increased.19 Of concern 
for public health practice is that the people who delay 
seeking emergency department healthcare may be at 
higher risk of IMD, such as young people, adolescents, 
and Aboriginal and Torres Strait Islander people.
Stigma was identified as a strong theme in this 
research, particularly in relation to seeking help within 
hospital settings, during recovery and re-entering 
the public sphere following infection. Treatment with 
antibiotics clears the bacteria and, once recovered, 
a person can move back into their community. Unlike 
IMD infection, the experiences of people living with 
other infectious diseases, particularly HIV infection 
and hepatitis C, have been described extensively.20,21 
HIV infection and hepatitis C can be managed or 
treated with medication, but are often characterised by 
uncertainty, fear and stigma.20,21 For people living with 
an infectious disease, stigma can include shunning, 
marginalisation, rejection and delayed presentation to a 
health professional.22,23 Barriers to accessing healthcare 
when living with an infectious disease have also been 
reported, along with social and economic effects.22 IMD is 
not a chronic infection like HIV infection and hepatitis C, 
but stigma associated with IMD has not been reported 
previously, and the implications of stigma for public health 
practice have not yet been fully explored. Support for 
those infected and their families during their hospital stay 
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and afterwards – with clear messages for communities 
that, once treated, the person poses no risk to others – 
may be pivotal in reducing the stigma associated with 
IMD and must be further investigated.
The health of Aboriginal people in Australia is poorer 
than that of non-Aboriginal people.24 The lived experience 
of racism is an important driver of poorer health status.18 
The negative impact of racism was described by one 
Aboriginal participant as causing parents of young 
children to delay presenting to healthcare facilities. 
Delay in seeking care because of racism may not be 
the experience of all Aboriginal communities or people, 
but any delay in seeking healthcare for IMD can affect 
the outcomes of the disease. This is a clear challenge 
for individuals and the healthcare system as a whole.18 
Steps towards addressing this challenge may include 
recognising and tackling institutional racism, developing 
fairness and compassion, and ensuring that culturally 
safe and appropriate healthcare is available.25
Communication – including what types of messages 
about IMD should be provided and the delivery 
methods for these messages – was a complex part of 
this research. Participants wanted information that was 
acceptable, accessible and appropriate. Each group 
said that understanding the signs and symptoms of IMD, 
and what actions to take, was important. Participants 
emphasised that ‘go-to’ or key people in a community 
were important to ensure that the dissemination of 
information is acceptable, as has been shown in other 
work.26 Go-to people are thought of as trustworthy by 
those affected, and as understanding the dynamics at 
work in their community. Communicating with higher 
risk groups using key people in the community requires 
further attention from public health practitioners.
Health services have traditionally used newspaper 
and television or radio news interviews to raise awareness 
of the signs and symptoms of IMD. These methods are 
potentially effective for some sectors of the community, 
but traditional sources of information were viewed by 
participants as outdated. Participants thought that use of 
technology, such as social networking applications and 
the internet, would be more effective and available at the 
precise time they were needed, and would assist with 
remembering disease details. This variety of methods 
acceptable for health messages may highlight the need 
for public health practice to continually adapt to the 
needs of different groups and levels of literacy, and to use 
new and emerging technology.
One element of research using a grounded theory 
approach is that researchers can bring their own history 
and cultural context into the research, which in turn can 
shape the researchers’ view of the data and generation 
of themes. To improve objectivity, all researchers were 
involved in separately coding data, and then coming 
together on multiple occasions to challenge and review 
themes and understanding. Researchers used diaries, 
reflective entries and examination of their own life 
experience in those entries to improve reflexivity.
Collecting data through community-based focus 
groups enabled participants from three high-risk groups, 
with a variety of literacy levels, to share information 
in a comfortable environment. Social interaction, and 
maximising the group dynamic to stimulate sharing, were 
facilitated by having groups with similar socio-economic 
and cultural backgrounds. A weakness of the methods 
used is that the results may not be representative of the 
wider population, because the number of participants 
and groups was small. The participants were identified 
through existing contacts of the research team, and the 
study was confined to one Local Health District. However, 
the results provide valuable insights for public health 
practice for notified cases and their affected communities.
Conclusion
Understanding of IMD was generally low among 
participants, with later-stage IMD symptoms better known 
than early-stage symptoms, which may result in delayed 
presentation to hospital. Other reasons described for 
delay in presentation for people in higher risk groups 
included cost, young people’s perceived invincibility, and 
racism. The need for clearer health messaging needs to 
be considered, along with addressing racism as a barrier 
to accessing health services.
Fear was a strong element of how people felt about 
and perceived IMD. Fear of stigma was felt to be 
important, particularly in relation to seeking help and 
during recovery from IMD. Public health practice around 
IMD might be strengthened if people and families are 
connected with support groups or other services to 
reduce the impact of IMD. Increasing understanding of 
how IMD is transmitted and treated, while addressing 
the feelings of fear and the perceived potential risk to 
others in communities, may have some impact on stigma 
for those affected. Communication about IMD may be 
improved by partnering with ‘go-to’ people – key people 
in high-risk groups who can help to reach communities 
where traditional modes of message delivery might 
not work. New technologies and social media were 
viewed as a more acceptable and appropriate method 
of communication about IMD for members of high-risk 
groups.
The findings from this small study may be used 
to generate hypotheses for further research. Lived 
experiences of IMD could be fully explored to inform 
further development of public health policy and practice, 
and encompass the understanding, perceptions and 
feelings of people in groups at higher risk for IMD.
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